References
- ChouguleAPrabhashKNoronhaVFrequency of EGFR mutations in 907 lung adenocarcinoma patients of Indian ethnicityPLoS One2013810e7616424124538
- RosellRCarcerenyEGervaisRSpanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia ToracicaErlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trialLancet Oncol201213323924622285168
- ZhouCWuY-LChenGErlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 studyLancet Oncol201112873574221783417
- MaemondoMInoueAKobayashiKNorth-East Japan Study GroupGefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFRN Engl J Med2010362252380238820573926
- YasudaHKobayashiSCostaDBEGFR exon 20 insertion mutations in non-small-cell lung cancer: preclinical data and clinical implicationsLancet Oncol2012131e23e3121764376
- NaidooJSimaCSRodriguezKEpidermal growth factor receptor exon 20 insertions in advanced lung adenocarcinomas: clinical outcomes and response to erlotinibCancer2015121183212322026096453
- Beau-FallerMPrimNRuppertA-MRare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT networkAnn Oncol201425112613124285021
- Lund-IversenMKleinbergLFjellbirkelandLHellandÅBrustugunOTClinicopathological characteristics of 11 NSCLC patients with EGFR-exon 20 mutationsJ Thorac Oncol2012791471147322895145
- OxnardGRLoPCNishinoMNatural history and molecular characteristics of lung cancers harboring EGFR exon 20 insertionsJ Thorac Oncol20138217918423328547
- SasakiHEndoKTakadaMEGFR exon 20 insertion mutation in Japanese lung cancerLung Cancer200758332432817686547
- PanYZhangYLiYPrevalence, clinicopathologic characteristics, and molecular associations of EGFR exon 20 insertion mutations in East Asian patients with lung adenocarcinomaAnn Surg Oncol201421suppl 4S490S49624419753
- WooHSAhnHKLeeHYEpidermal growth factor receptor (EGFR) exon 20 mutations in non-small-cell lung cancer and resistance to EGFR-tyrosine kinase inhibitorsInvest New Drugs20143261311131525146938
- XingKZhouXZhaoXA novel point mutation in exon 20 of EGFR showed sensitivity to erlotinibMed Oncol20143173624908064
- WuJ-YWuS-GYangC-HLung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment responseClin Cancer Res200814154877488218676761
- OxnardGRArcilaMESimaCSAcquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: distinct natural history of patients with tumors harboring the T790M mutationClin Cancer Res20111761616162221135146